Diabetes affect over 16 million Americans of all ages and socioeconomic groups.
With an annual death rate of 150,000 and with an annual cost to treat diabetes around $100 billion, diabetes is one of the deadliest and costliest diseases in the U.S.
Most of the morbidity and mortality of diabetes is due to the complications of diabetes.
Improved blood glucose control, regular eye exams, and reduction in cholesterol and blood pressure are some of the practices that have been unequivocally shown to reduce complications and the heavy personal and financial toll of the disease.
However, data collected from quality improvement projects conducted in both the fee-for-service and managed care settings indicate underutilization of these services.
The goal of the national Diabetes Quality Improvement Project (DQIP) is to create consensus around a single set of diabetes measures for performance reporting.
DQIP Data Abstraction Tool Kit
Our DQIP Data Abstraction Tool Kit can help you measure the quality of health care you deliver to your diabetes patients.
DQIP Background
General information about the DQIP project
Quality Improvement Tools
Downloadable sample tools from other Quality Improvement Organizations
DQIP 1.2 Specifications
Methodology to measure the quality of diabetes care
Compendium of Best Practices
Information on how to deliver the best care for diabetes
Related Sites
Other web sites with useful information
- Compendium of Diabetes Best Practices
- Data Abstraction Tool Kit
- Diabetes Brochure
- Diabetes Flow Sheet
- Diabetes Mellitus Web Site and Telephone Reference List
- Diabetes Resource List
- DQIP 1.2 Specifications
- DQIP Background
- DQIP Leadership Council
- DQIP Participants
- DQIP Technical Panel
- Quality Improvement Tools
- Related Web Sites
DQIP Projects
- Development and Validation of a Novel Drug Testing Methodology for Detecting Diabetes-Related Medications
- Evaluating the Impact of Marijuana Use on Insulin Sensitivity and Glucose Metabolism in Type 2 Diabetic Patients
- Constructing a Comprehensive Database of Marijuana Strains and their Potential Impacts on Blood Glucose Levels in Diabetic Patients: A Pioneering Endeavor
- An Exploration into the Potential of Cannabinoids for Diabetes-Related Complications: A Groundbreaking Investigation
- A Comprehensive Evaluation of the Clinical Trial: A New Frontier in Diabetes Management
- Building Bridges in Healthcare: Standardizing Medical Marijuana Discussions within WVDirect
- Pushing Digital Frontiers: Integrating AI to Analyze Drug Test Results within WVDirect
- Promoting Comprehensive Care: Implementing Medical Marijuana Documentation Guidelines within WVDirect
- Incorporating Workplace Safety Guidelines into WVDirect” Introduction
- A Chronicle of Integrating Drug Testing Laboratories with WVDirect